Does HUMAN IMMUNOGLOBULIN G Cause Stent placement? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Stent placement have been filed in association with HUMAN IMMUNOGLOBULIN G (BIVIGAM). This represents 0.0% of all adverse event reports for HUMAN IMMUNOGLOBULIN G.
23
Reports of Stent placement with HUMAN IMMUNOGLOBULIN G
0.0%
of all HUMAN IMMUNOGLOBULIN G reports
0
Deaths
16
Hospitalizations
How Dangerous Is Stent placement From HUMAN IMMUNOGLOBULIN G?
Of the 23 reports, 16 (69.6%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN IMMUNOGLOBULIN G Cause?
Headache (7,885)
Off label use (5,872)
Fatigue (5,423)
Nausea (4,454)
Sinusitis (4,409)
Pyrexia (4,076)
Drug ineffective (3,923)
Pruritus (3,775)
Dyspnoea (3,518)
Malaise (3,180)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which HUMAN IMMUNOGLOBULIN G Alternatives Have Lower Stent placement Risk?
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN IMMUNOGLOBULIN G vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMAN IMMUNOGLOBULIN G vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G vs HUMAN RHO IMMUNE GLOBULIN